Feedback / Questions
nanoencapsulated paclitaxel (FID-007) - ANP Technologies, Fulgent Genetics
https://www.businesswire.com/news/home/20240603406357/en/Fulgent-Data-at-ASCO-2024-Highlights-Antitumor-Activity-from-Lead-Therapeutic-Oncology-Candidate-FID-007-in-Head-and-Neck-Cancer
Jun 3, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next